Feed Insights Top Reports Pricing

⌘K

16:31:28·757d

SECFilingvia Quantisnow

SEC Form DEF 14A filed by Fiserv Inc.

ByQuantisnow·Wall Street's wire, on your screen.

FI· Fiserv Inc.

Real Estate

Original source

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FI (Fiserv Inc.) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

FI
Fiserv Inc.
Real Estate

Recent analyst ratings

Nov 5UpdateBNP Paribas Exane$62.00
Oct 30UpdateArgus-
Oct 30UpdateB. Riley Securities-
Oct 30UpdateGoldman$79.00
Oct 30UpdateSeaport Research Partners-
Oct 30UpdateTD Cowen$80.00

Related

INSIDER162d
Chief Accounting Officer Best Kenneth was granted 12,228 shares, increasing direct ownership by 31% to 51,124 units (SEC Form 4)
SEC168d
Amendment: SEC Form SCHEDULE 13G/A filed by Fiserv Inc.
SEC171d
SEC Form CERT filed by Fiserv Inc.
SEC171d
SEC Form 25 filed by Fiserv Inc.
PR174d
Fiserv to Participate in Upcoming Investor Conferences
PR175d
Fiserv Recognized as a Leader in IDC MarketScape for North America Retail Digital Banking Solutions
ANALYST176d
Fiserv downgraded by BNP Paribas Exane with a new price target
INSIDER177d
New insider Todd Paul M claimed ownership of 7,453 shares (SEC Form 3)

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds Follow on Google News

Top lists

Trending By market cap Active companies Insider purchases FDA approvals Short volume screener Sectors Market reports

Browse

By event category By exchange Earnings calendar Dividend tracker Insider tracker IPO calendar Compare stocks

Publish

Publish an article Amend a newsitem Pricing Guidelines Terms

Company

About Pricing Refer a trader25%Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022